Memorial Hermann Health System, a non-profit health system in Houston, Texas, US has invested in intelligent care enablement platform Memora Health.

The investment, whose size was not disclosed, is part of a financing round that also saw the participation of other investors apart from Memorial Hermann.

Among these investors are Northwell Holdings and NorthShore-Edward-Elmhurst Health.

By leveraging Memora's AI-driven technology, routine elements of care journeys, such as answering frequently asked questions and ensuring medication adherence, can be digitised and automated.

This is expected to boost patient engagement, allow providers to focus more on care, and deliver proactive education, simplifying complex care journeys for clinicians and patients.

Memorial Hermann executive vice-president and chief strategy officer Feby Abraham said: “As a community-focused health system, we’re always looking to invest in new digital technologies that will enable us to better meet the diverse needs of our patients across the Greater Houston area, while also supporting our providers and physician partners.

“Memora’s focus on complex care journeys is a key differentiator and ensures care teams can deliver high-touch, personalised care to patients across a breadth of clinical care programs.”

Memora's platform employs AI and natural language processing to handle routine tasks and screen for changes in symptoms and health status.

The investment in the platform aligns with Memorial Hermann's commitment to transform its enterprise using digital health solutions.

Memora co-founder and CEO Manav Sevak said: “We are thrilled to support Memorial Hermann in its vision to create healthier communities, now and for generations to come.

“We believe this strategic investment will help simplify and improve the care journey for patients once they make the move outside the four walls of the hospital and back into their homes.”